These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33427531)

  • 1. Advances in
    Khanna S
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1067-1070. PubMed ID: 33427531
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
    Khanna S; Pardi D
    Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
    [No Abstract]   [Full Text] [Related]  

  • 4. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent
    Satokari R; Pietilä L; Mattila E; Lahtinen P; Arkkila PET
    Infect Dis (Lond); 2020 Sep; 52(9):662-665. PubMed ID: 32516025
    [No Abstract]   [Full Text] [Related]  

  • 6. Fecal microbiota transplantation as an early therapeutic option in treatment refractory Clostridioides difficile infection.
    Buldukoglu OC; Ocal S; Cekin AH
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1200. PubMed ID: 38454297
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
    Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
    [No Abstract]   [Full Text] [Related]  

  • 8. Breaking the Cycle of Recurrent
    Herbin SR; Crum H; Gens K
    J Pharm Pract; 2024 Dec; 37(6):1361-1373. PubMed ID: 38739837
    [No Abstract]   [Full Text] [Related]  

  • 9. Faecal microbiota transplantation for eradication of co-infection with
    Bahl MI; Jørgensen SMD; Skriver AH; Larsen NA; Wang M; Licht TR; Dahlerup JF; Hvas CL
    Scand J Gastroenterol; 2020 May; 55(5):626-630. PubMed ID: 32324085
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation: The Evolving Risk Landscape.
    Gupta S; Mullish BH; Allegretti JR
    Am J Gastroenterol; 2021 Apr; 116(4):647-656. PubMed ID: 33982930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
    Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
    Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection.
    Hunt A; Drwiega E; Wang Y; Danziger L
    Am J Health Syst Pharm; 2024 Jul; 81(15):e402-e411. PubMed ID: 38470061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological mechanisms of fecal microbiota transplantation in recurrent
    Soveral LF; Korczaguin GG; Schmidt PS; Nunes IS; Fernandes C; Zárate-Bladés CR
    World J Gastroenterol; 2022 Sep; 28(33):4762-4772. PubMed ID: 36156924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.
    Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS
    Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683
    [No Abstract]   [Full Text] [Related]  

  • 16. Escape Velocity-the Launch of Microbiome Therapies.
    Kelly BJ; Kwon JH; Woodworth MH
    J Infect Dis; 2024 Jul; 230(1):2-4. PubMed ID: 39052747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise to the Challenge: Master the Management of Clostridioides difficile Infection.
    Voth E; Khanna S
    Mayo Clin Proc; 2024 Jun; 99(6):971-979. PubMed ID: 38839189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.